Robust sustained release formulations of oxymorphone and methods of use thereof

Details for Australian Patent Application No. 2006349472 (hide)

Owner Penwest Pharmaceuticals Co.

Inventors Baichwal, Anand R.; Fitzmaurice, Kevin; Howard-Sparks, Michelle; Labudzinski, Steve; Rychtman, Allen; Hein, William

Agent Davies Collison Cave

Pub. Number AU-A-2006349472

PCT Pub. Number WO2008/045047

Filing date 10 October 2006

Wipo publication date 17 April 2008

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/045047 Priority application(s): WO2008/045047

25 February 2010 Amendment Made

  The nature of the amendment is: Delete the co-inventor Rychtman, Allen 2007

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006349481-IMS device reconfiguration

2006349471-Robust sustained release formulations of oxymorphone